Unveiling The Myth of High Recurrence Rate of Extracranial Arteriovenous Malformations of The Head and Neck: Systematic Review of Case Reports and Case Series
F1000Research · 2024
DOI: 10.12688/f1000research.147233.2 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift F1000Research, 2024. Verfasst von Agustian Winarno Putra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Sardjito General Hospital, Sleman, Yogyakarta, 55281, Indonesia. Hauptthemen laut MEDLINE: Arteriovenous Malformations, Neck, Head. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Arteriovenous malformations (AVMs) in the head and neck pose a challenge in their management due to their local aggressiveness and high recurrence risk. This study aimed to analyze literature on head and neck AVM recurrence post-treatment and identify the most effective strategy with a lower recurrence rate.
Objectives
To analyse existing literature on the recurrence of head and neck AVMs following treatment. Our goal was to identify the most effective treatment option with a lower recurrence rate.
Methods
We conducted a thorough literature search using PubMed, ScienceDirect, and Scopus, from year 2000 to the present. Our analysis focused on key endpoints, specifically the recurrence rates of head and neck AVMs following various treatment approaches.
Results
Out of the initial pool of 108 screened articles, a total of 83 patients were deemed suitable for inclusion in the literature review. The reviewed articles demonstrated that appropriate diagnostic tests were documented in 95% of the included studies. Among the patients, 37.3% had previously undergone interventions and were currently dealing with regrowth masses. Notably, 55.4% of patients underwent a combined approach involving both endovascular and surgical methods, while 25.3% opted for a surgical-only approach, and only 19.3% pursued an endovascular-only approach. The studies showed a promising curing rate of AVMs, with a success rate of 94%, albeit with a complication rate of 32.5%. The average follow-up duration for all patients was 26 months, with a standard deviation of 20.5 months. Out of the 83 patients, 5 experienced recurrence, with single-modality approach. Interestingly, no patients who received a multi-modality of treatments experienced recurrence or regrowth of the AVM mass within the follow up period.
Conclusion
The multi-modality approach outperformed single-modality treatments in preventing AVM recurrence. These findings highlight the importance of a comprehensive and multidisciplinary approach in the management of these complex vascular anomalies. PROSPERO: CRD42023490871 registered on 17/12/2023
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dr. Sardjito General Hospital, Sleman, Yogyakarta, 55281, Indonesia.
- Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Nursing, and Public Health Universitas Gadjah Mada, Sleman, Yogyakarta, 55281, Indonesia.
ORCID-Profile: Agustian Winarno Putra, Sagung Rai Indrasari, Camelia Herdini, Danu Yudistira
Zitieren
APA
Putra, A. W., Indrasari, S. R., Herdini, C., & Yudistira, D. (2024). Unveiling The Myth of High Recurrence Rate of Extracranial Arteriovenous Malformations of The Head and Neck: Systematic Review of Case Reports and Case Series. F1000Research. https://doi.org/10.12688/f1000research.147233.2
Vancouver
Putra AW, Indrasari SR, Herdini C, Yudistira D. Unveiling The Myth of High Recurrence Rate of Extracranial Arteriovenous Malformations of The Head and Neck: Systematic Review of Case Reports and Case Series. F1000Research. 2024. doi:10.12688/f1000research.147233.2
BibTeX
@article{Putra2024,
author = {Putra, Agustian Winarno and Indrasari, Sagung Rai and Herdini, Camelia and Yudistira, Danu},
title = {Unveiling The Myth of High Recurrence Rate of Extracranial Arteriovenous Malformations of The Head and Neck: Systematic Review of Case Reports and Case Series},
journal = {F1000Research},
year = {2024},
doi = {10.12688/f1000research.147233.2}
}
EUVIMED